To assess the possible involvement of mast cells and/or their mediators in
inflammatory bowel diseases, the effect of the histamine H-1 antagonist Dit
hiaden was studied on a model of acetic acid-induced colitis in rats. Dithi
aden pretreatment by intracolonic administration was found to reduce the ex
tent of acute inflammatory colonic injury. This was manifested by a decreas
e in the score of gross mucosal injury, by lowered colonic wet weight and b
y diminished myeloperoxidase activity reflecting reduced leukocyte infiltra
tion. Vascular permeability and gamma-glutamyl transpeptidase activity, ele
vated by acetic acid exposure, were decreased after Dithiaden pretreatment.
The results indicate that locally administered Dithiaden may protect the c
olonic mucosa against an acute inflammatory attack by interfering with the
action of the major mast cell mediator histamine.